MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Decoy Therapeutics Inc. (DCOY)
Decoy Therapeutics Inc. (DCOY)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$468,500
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from issuance of equity...
Equity-based compensation
Depreciation and amortization
Negative Cash Flow Breakdown
Net loss
Accounts payable
Deferred revenue
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
Net loss
-2,373,800
-2,224,628
-12,518,480
Depreciation and amortization
13,632
5,924
7,151
Equity-based compensation
206,177
213,044
219,058
Change in fair value of warrant liability
-
-
-6,540
In-process research and development expense
-
-
8,517,966
Prepaid expenses and other current assets
11,026
261,821
-419,628
Accounts payable
-230,614
-4,556
-1,167,068
Accrued expenses and other
-28,759
-617,292
-298,903
Deferred revenue
-227,629
-
-
Net cash used in operating activities
-2,652,019
-2,889,329
-4,827,188
Issuance of promissory loan in connection with asset acquisition
-
-
577,000
Cash received from asset acquisition, net of cash paid
-
-
1,341,735
Purchase of fixed assets
42,424
-
-
Net cash used in investing activities
-42,424
-
764,735
Proceeds from issuance of equity securities, net
3,162,943
0
12,559,728
Payments on note payable
0
0
221,866
Net cash provided by financing activities
3,162,943
0
12,337,862
Net decrease in cash
468,500
-2,889,329
8,275,409
Cash, cash equivalents, and restricted cash at beginning of period
7,820,608
10,709,937
2,434,528
Cash, cash equivalents, and restricted cash at end of period
8,289,108
7,820,608
10,709,937
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
DCOY Cash Flow Sankey Diagram
Sankey diagram visualizing DCOY cash flow for the period
Proceeds from issuance of
equity securities, net
$3,162,943
Net cash provided by
financing activities
$3,162,943
Net decrease in cash
$468,500
Canceled cashflow
$2,694,443
Equity-based compensation
$206,177
Depreciation and
amortization
$13,632
Net cash used in
operating activities
-$2,652,019
Net cash used in
investing activities
-$42,424
Canceled cashflow
$219,809
Net loss
-$2,373,800
Accounts payable
-$230,614
Deferred revenue
-$227,629
Purchase of fixed assets
$42,424
Accrued expenses and
other
-$28,759
Prepaid expenses and
other current assets
$11,026
Buy us a coffee